OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...
Stargate is little more than an extension of Sam Altman's powerful AI company, anonymous sources told the Financial Times.
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
An icon in the shape of a lightning bolt. Impact Link Over the years, OpenAI CEO Sam Altman has shared predictions about where he thinks we're headed on artificial general intelligence ...
Retro Biosciences is raising $1 billion, with the ultimate goal of using its customized AI to extend human lifespan by 10 ...
We recently published a list of 10 AI News You Should Definitely Take a Look At. In this article, we are going to take a look ...